Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD

American Journal of Kidney Diseases

Volumn 33, Issue 2, 1999, Pages 318-324

  Lai, K N ^a   Szeto, C C ^a   Lai, K B ^a   Lam, C W K ^a   Chan, D T M ^a   Leung, J C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CAPD; Hyaluronan; Macrophages; Mesothelial cells; Peritoneal transport; Peritonitis

Indexed keywords

HYALURONIC ACID;

ADULT; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORRELATION FUNCTION; DIALYSATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; PERITONEUM CELL; PERITONITIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; ULTRAFILTRATION;

EID: 0033006996     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70307-0     Document Type: Article

References (28)

1. N Di Paolo G Sacchi M De Mia E Gaggiotti L Cagotondo P Rossi M Bernini AM Pucci L Ibba P Sabatelli Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis Nephron 44 1986 204 211
2. VC Gandhi HM Humayun TS Ing JT Daugirdas VR Jablokow S Iwatsuki WP Geis JE Hano Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 140 1980 1202 1203
3. CA Pollock LS Ibels RP Eckstein JC Graham RJ Caterson JF Mahony AG Sheil Peritoneal morphology on maintenance dialysis Am J Nephrol 9 1989 198 204
4. RM Mason Recent advances in the biochemistry of hyaluronan Prog Clin Biol Res 54 1981 87 112
5. TC Laurent JRE Fraser Hyaluronan FASEB J 6 1992 2397 2404
6. AJ Fosang NJ Hey SL Carney TE Hardingham An ELISA plate assay for hyaluronan using biotinylated proteoglycan G1 domain Matrix 10 1990 305 313
7. A Engstrom-Laurent N Feltelius R Hallgren P Waterson Elevated serum hyaluronate in scleroderma. An effect of growth factor induced activation of connective tissue cells Ann Rheum Dis 44 1985 614 620
8. R Hallgren A Engstrom-Laurent V Nisbeth Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uraemia Nephron 46 1987 150 154
9. E Honkanen B Froseth C Gronhagen-Riska Serum hyaluronic acid and procollagen III amino terminal peptide in chronic renal failure Am J Nephrol 11 1991 201 206
10. GW Lipkin MA Forbes EH Cooper JH Turney Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 8 1993 357 360
11. S Yung GA Coles JD Williams M Davies The source and possible significance of hyaluronan in the peritoneal cavity Kidney Int 46 1994 527 533
12. MM Pannekeet D Zemel GCM Koomen DG Struijk RT Krediet Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD Perit Dial Int 15 1995 217 225
13. ZJ Twardowski The fast peritoneal equilibration test Semin Dial 3 1990 141 142
14. TWL Mak CK Cheung CMF Cheung CB Leung CWK Lam KN Lai Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations Nephrol Dial Transplant 12 1997 184 186
15. RT Krediet EW Boeschoten FMJ Zuyderhoudt J Strackee L Arisz Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients Blood Purif 4 1986 194 203
16. KN Lai KB Lai CC Szeto KKL Ho P Poon CWK Lam JCK Leung Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: Their relationship with transport parameters Am J Kidney Dis 29 1997 699 705
17. 3H] glucosamine incorporation into hyaluronic acid by fibroblasts is modulated by culture conditions Matrix 10 1990 75 83
18. R Selgas MJ Fernandez-Reyes E Bosque MA Bajo F Berrego C Jimenez G Del Peso F De Alvaro Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis? Result of a prospective medium long-term study Am J Kidney Dis 23 1994 64 73
19. SJ Davies J Bryan L Phillips GI Russell Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis Nephrol Dial Transplant 11 1996 498 506
20. WK Lo A Brendolan BF Prowant HL Moore R Khanna ZJ Twardowski KD Nolph Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients J Am Soc Nephrol 4 1994 1466 1474
21. MY Viksman MC Liu CA Bickel RP Schleimer BS Bochner Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma Am J Respir Crit Care Med 155 1997 858 863
22. EN Bos H van Bronswuk TJM Helmerhorst LP Oe ECM Hoffsmit RHJ Beelen Distinct populations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy: A study of peroxidatic activity J Leukoc Biol 43 1988 172 178
23. A Brauner B Hylander B Wretlind Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 27 1996 402 408
24. TC Laurent JRE Fraser The properties and turnover of hyaluron D Evered J Whelan Functions of Proteoglycans. Ciba Foundation Symposium vol 124 1986 Wiley Chichester, NY 9 29
25. MW Fieren GJ van den Bemd IL Bonta Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show increased capacity to release interleukin-1 beta in vitro during peritonitis Eur J Clin Invest 20 1990 453 457
26. Y Hamura A Ito Y Okada Y Mori Hyaluronic acid metabolism in inflamed mesenterium of guinea pig Res Commun Chem Pathol Pharmacol 66 1989 311 327
27. S Yung GA Coles M Davies IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD Kidney Int 50 1996 1337 1343
28. T Wang HH Cheng O Heimburger J Waniewski J Bergstrom B Lindholm Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume Kidney Int 53 1998 496 502